Efficacy of Vonoprazan for sleeping dysorder caused by gastroesophageal reflux disease (GERD) symptoms.
Not Applicable
- Conditions
- gastroesophageal reflux disease (GERD)
- Registration Number
- JPRN-UMIN000021521
- Lead Sponsor
- Machida municipal hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Having oral medicine which may effect gastrointestinal motility. Equivalent to contraindications of the package insert of Vonaprazan. No history of upper gastrointestinal operation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method An improvement of the sleeping dysorder caused by GERD, in 4, 8, 12 and 16 weeks after start of administration.
- Secondary Outcome Measures
Name Time Method